|
|
Volumn 7, Issue 4, 1997, Pages 353-369
|
|
Antipsychotic drugs: Recent developments and novel agents
a
|
|
Author keywords
Antipsychotic drugs; Clozapine; Dopamine; Glutamate; N methyl D aspartate; Neurokinin; Nicotine; Risperidone; Schizophrenia; Serotonin; Sigma receptors
|
|
Indexed keywords
CLOZAPINE;
DOPAMINE;
DOPAMINE 4 RECEPTOR;
DOPAMINE RECEPTOR BLOCKING AGENT;
GLUTAMATE RECEPTOR ANTAGONIST;
GLUTAMIC ACID;
HALOPERIDOL;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
NEUROKININ;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
SEROTONIN 1 ANTAGONIST;
SEROTONIN 2 ANTAGONIST;
SEROTONIN 3 ANTAGONIST;
SEROTONIN 4 ANTAGONIST;
SIGMA OPIATE RECEPTOR;
TACHYKININ RECEPTOR ANTAGONIST;
ZIPRASIDONE;
AGRANULOCYTOSIS;
DRUG DEVELOPMENT;
HUMAN;
NONHUMAN;
PATENT;
REVIEW;
SCHIZOPHRENIA;
|
|
EID: 0030794926
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: 10.1517/13543776.7.4.353 Document Type: Review |
|
Times cited : (6)
|
|
References (34)
|
